This site is intended for healthcare professionals only
LoginRegister
Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing PlantLupin Gets CDSCO Panel Nod to Study Antidiabetic FDC
Novartis AG to Exit India Arm in Rs 1,446 Cr Deal, ChrysCapital-Led Consortium Buys 70.68% StakeCDSCO Panel Approves Novartis's Protocol Amendment Proposal to Study Ianalumab
CDSCO Panel Rejects Hetero Labs Plea for Lenacapavir Approval Without Local TrialsHetero Labs Gets CDSCO Panel Nod to Study Vonoprazan Tablet
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertCDSCO panel approves Sanofi Healthcare's protocol amendment proposal to study SAR441566
After 40 Years, USFDA Approves Vanda Pharmas Motion Sickness Drug NereusIndoco Remedies Varenicline Tablets gets USFDA nod to aid smoking cessation treatment
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJohnson and Johnson gets European Commission nod for expanded use of HIV 1 therapy Edurant in...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIAIQVIA Gets CDSCO Panel Nod to Study KarXT in Schizophrenia
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertSanofi gets CDSCO Panel nod to study Amlitelimab
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsLa Renon's plea to exempt Sodium Valproate from NPPA price cap rejected
Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans AppealAbbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaAstraZeneca Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentMerck acquires cancer therapy developer Modifi Biosciences
X